Oxybutynin Chloride Syrup
Product Images NDC 17856-0149

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 17856-0149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ud Label (17856 0149 1)

Ud Label (17856 0149 1)
Label for Oxybutynin Chloride Syrup USP 5 mg/5 mL, an oral human prescription drug. The label shows a package quantity of 72 cups and instructions to store at controlled room temperature between 15°C and 30°C (59°F and 86°F). It is packaged by Unit Dose Solutions and distributed by Atlantic Biologicals Corp. The label includes a barcode, lot number, expiration date, and a reorder phone number.*
FDA Label Image

Structure Of Oxybutynin (Oxybutynin Chloride 1)

Structure Of Oxybutynin (Oxybutynin Chloride 1)
Chemical structure diagram of oxybutynin chloride, showing the molecular arrangement and the hydrochloride salt component (HCl).*
FDA Label Image

Figure1 (Oxybutynin Chloride 2)

Figure1 (Oxybutynin Chloride 2)
A line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours after dosing with Oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows the concentration in ng/mL. Data points include error bars indicating variability at multiple time points throughout the dosing period.*
FDA Label Image

Figure1 (Oxybutynin Chloride 3)

Figure1 (Oxybutynin Chloride 3)
A line graph comparing mean oxybutynin plasma concentration (ng/mL) over time (hours) after administration of Oxybutynin Chloride 5 mg syrup and 5 mg immediate-release (IR) tablet. The graph shows concentration decreasing from 0 to 12 hours, with error bars for variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.